Huge congratulations to our incredible mentor, Dr. Mariana Chavez MacGregor, on being named @MDAndersonNews Mentor of the Year! I’m greatly appreciative of your guidance, unwavering support and sponsorship. So well deserved! ✨
To all SITC members - election starts May 2 and I would strongly encourage consideration of Dr. Tina Cascone as a dynamic and visionary physician scientist and translational researcher. A true pioneer and leader in the lung cancer space. @sitcancersitcancer.org/membership/202…
We are pleased to announce that Timothy A. Yap, MBBS, PhD, of The University of Texas MD Anderson Cancer Center, has been appointed Editor-in-Chief of Clinical Cancer Research. Learn More: brnw.ch/21wQV12
We’re days out from the ice storm that will impact blood supply @MDAndersonNews. Take 30 minutes this weekend (or during a half day on Monday) to make a difference by donating blood for our cancer patients. Make an appointment at MDAndersonBloodBank.org. #EndCancer
Starting tomorrow, MD Anderson experts will present the latest advances in cancer care at the European Society for Medical Oncology Congress.
Read highlights from presentations and details about onsite opportunities: MDAnderson.org/ESMO@myESMO#ESMO24#EndCancer
Our Dr. Jason Westin shares insights on how CAR-T therapy could improve first-line therapy in some lymphoma patients: bit.ly/3VXzPNv@Lymphoma_Doc#EndCancer
It was an honor to be part of the plenary session — especially to celebrate progress for patients with lung cancer and be with wonder colleagues. #LCSM
“ADRIATIC is the first positive global Phase III trial of immunotherapy for limited stage small cell #LungCancer,” says our Dr. @LaurenByersMD at #ASCO24. “This groundbreaking trial sets a new standard of care with consolidative durvalumab following concurrent chemoradiotherapy.” @ASCO#EndCancer
The antibody drug conjugate M9140 demonstrates promising activity in heavily pretreated patients with advanced #ColorectalCancer.
Read about the findings presented by our Dr. Scott Kopetz (Abstract 3000) at #ASCO24: bit.ly/4bHkgzc@skopetz@ASCO#EndCancer
Congratulations to @KellyKhunt on your induction into @OncLive's 12th Annual Giants of Cancer Care recognition program! Recognizing your contributions to breast cancer research and patient care @MDAndersonNews#OncSurgery#EndCancer
Drugs that got accelerated approval may be the only option for patients with rare or advanced cancers, says our Dr. Jennifer Litton. “It’s important for doctors to carefully explain the evidence.”
Learn more: brnw.ch/21wID60@AP@JenniferLitton#EndCancer